{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T05:35:45Z","timestamp":1793424945318,"version":"4.5.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Elevated activity of retrotransposons is increasingly recognized to be implicated in a wide range of neurodegenerative and neurodevelopmental diseases, including Down syndrome (DS), which is the most common chromosomal condition causing intellectual disability globally. Previous research by our group has revealed that treatment with lamivudine, a reverse transcriptase inhibitor, improved neurobehavioral phenotypes and completely rescued hippocampal-dependent recognition memory in a DS mouse model, Ts65Dn. We hypothesized that retrotransposition rates would increase in the Ts65Dn mouse model, and lamivudine could block retrotransposons. We analyzed the differentially expressed long interspersed element-1 (LINE-1 or L1) mapping on MMU16 and 17, and showed for the first time that retrotransposition could be associated with Ts65Dn\u2019s pathology, as misregulation of L1 was found in brain tissues associated with trisomy. In the cerebral cortex, 6 out of 26 upregulated L1s in trisomic treated mice were located in the telomeric region of MMU16 near <jats:italic>Ttc3<\/jats:italic>, <jats:italic>Kcnj6<\/jats:italic>, and <jats:italic>Dscam<\/jats:italic> genes. In the hippocampus, one upregulated L1 element in trisomic treated mice was located near the <jats:italic>Fgd4<\/jats:italic> gene on MMU16. Moreover, two downregulated L1s rescued after treatment with lamivudine were located in the intronic region of <jats:italic>Nrxn1<\/jats:italic> (MMU17) and <jats:italic>Snhg14<\/jats:italic> (MMU7), implicated in a variety of neurodegenerative disorders. To gain further insight into the mechanism of this improvement, we here analyzed the gene expression profile in the hippocampus and cerebral cortex of trisomic mice treated and no-treated with lamivudine compared to their wild-type littermates. We found that treatment with lamivudine rescued the expression of 24% of trisomic genes in the cortex (located on mouse chromosome (MMU) 16 and 17) and 15% in the hippocampus (located in the human chromosome 21 orthologous regions), with important DS candidate genes such as <jats:italic>App<\/jats:italic> and <jats:italic>Ets2<\/jats:italic>, rescued in both regions.<\/jats:p>","DOI":"10.3389\/fnagi.2024.1386944","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:37:45Z","timestamp":1721363865000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Lamivudine modulates the expression of neurological impairment-related genes and LINE-1 retrotransposons in brain tissues of a Down syndrome mouse model"],"prefix":"10.3389","volume":"16","author":[{"given":"Alessandra","family":"Borgognone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Casadell\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Mart\u00ednez de Lagr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonaventura","family":"Clotet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Dierssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleix","family":"Elizalde-Torrent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"5766","DOI":"10.1038\/s41380-020-0806-5","article-title":"Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain","volume":"26","author":"Ali\u0107","year":"2021","journal-title":"Mol. Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuroscience.2022.07.015","article-title":"Neuronal nuclear tau and neurodegeneration","volume":"518","author":"Ant\u00f3n-Fern\u00e1ndez","year":"2023","journal-title":"Neuroscience"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.chembiol.2019.04.010","article-title":"Synthesis and characterization of specific reverse transcriptase inhibitors for mammalian LINE-1 retrotransposons","volume":"26","author":"Banuelos-Sanchez","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1146\/annurev-genom-082509-141802","article-title":"LINE-1 elements in structural variation and disease","volume":"12","author":"Beck","year":"2011","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"e1006453","DOI":"10.1371\/journal.pcbi.1006453","article-title":"Telescope: characterization of the retrotranscriptome by accurate estimation of transposable element expression","volume":"15","author":"Bendall","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1101\/gr.8.9.940","article-title":"Physical and comparative mapping of distal mouse chromosome 16","volume":"8","author":"Cabin","year":"1998","journal-title":"Genome Res."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nn.2600","article-title":"Olig1 and Olig2 triplication causes developmental brain defects in down syndrome","volume":"13","author":"Chakrabarti","year":"2010","journal-title":"Nat. Neurosci."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"566922","DOI":"10.3389\/fnagi.2020.566922","article-title":"Interleukin-17A: the key cytokine in neurodegenerative diseases","volume":"12","author":"Chen","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3389\/fnbeh.2015.00268","article-title":"Dissecting Alzheimer disease in down syndrome using mouse models","volume":"9","author":"Choong","year":"2015","journal-title":"Front. Behav. Neurosci."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.2147\/JIR.S280953","article-title":"Interferon-driven immune dysregulation in down syndrome: a review of the evidence","volume":"14","author":"Chung","year":"2021","journal-title":"J. Inflamm. Res."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/nature08248","article-title":"L1 retrotransposition in human neural progenitor cells","volume":"460","author":"Coufal","year":"2009","journal-title":"Nature"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"210091","DOI":"10.1098\/rsob.210091","article-title":"Emerging evidence implicating a role for neurexins in neurodegenerative and neuropsychiatric disorders","volume":"11","author":"Cuttler","year":"2021","journal-title":"Open Biol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41586-018-0784-9","article-title":"L1 drives IFN in senescent cells and promotes age-associated inflammation","volume":"566","author":"De Cecco","year":"2019","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e1009317","DOI":"10.1371\/journal.pcbi.1009317","article-title":"Meta-analysis of transcriptomic data reveals clusters of consistently deregulated gene and disease ontologies in down syndrome","volume":"17","author":"De Toma","year":"2021","journal-title":"PLoS Comput. Biol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1126\/SCITRANSLMED.ABL6057","article-title":"LINE-1RNA causes heterochromatin erosion and is a target for amelioration of senescent phenotypes in progeroid syndromes","volume":"14","author":"Della Valle","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nrn3314","article-title":"Down syndrome: the brain in trisomic mode","volume":"13","author":"Dierssen","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.18632\/aging.102677","article-title":"Down syndrome and Alzheimer\u2019s disease: common molecular traits beyond the amyloid precursor protein","volume":"12","author":"Gomez","year":"2020","journal-title":"Aging"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cell.2008.09.022","article-title":"Retrotransposons revisited: the restraint and rehabilitation of parasites","volume":"135","author":"Goodier","year":"2008","journal-title":"Cell"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.gde.2012.02.006","article-title":"Active human retrotransposons: variation and disease","volume":"22","author":"Hancks","year":"2012","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1523\/JNEUROSCI.5107-04.2005","article-title":"Ets-2 promotes the activation of a mitochondrial death pathway in Down\u2019s syndrome neurons","volume":"25","author":"Helguera","year":"2005","journal-title":"J. Neurosci."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e1003470","DOI":"10.1371\/journal.pgen.1003470","article-title":"Transposable elements are major contributors to the origin, diversification, and regulation of vertebrate long noncoding RNAs","volume":"9","author":"Kapusta","year":"2013","journal-title":"PLoS Genet."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1126\/science.1089670","article-title":"Mobile elements: drivers of genome evolution","volume":"303","author":"Kazazian","year":"2004","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"10488","DOI":"10.1093\/nar\/gku687","article-title":"Potential for genomic instability associated with retrotranspositionally-incompetent L1 loci","volume":"42","author":"Kines","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2017.03.009","article-title":"Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of down syndrome","volume":"103","author":"Kleschevnikov","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1038\/s41467-020-16907-0","article-title":"MeCP2 regulates gene expression through recognition of H3K27me3","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1371\/JOURNAL.PONE.0044099","article-title":"Transposable elements in TDP-43-mediated neurodegenerative disorders","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8490","DOI":"10.1111\/jcmm.16811","article-title":"Lamivudine improves cognitive decline in SAMP8 mice: integrating in vivo pharmacological evaluation and network pharmacology","volume":"25","author":"Li","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2330","DOI":"10.1093\/hmg\/dds052","article-title":"OLIG2 over-expression impairs proliferation of human down syndrome neural progenitors","volume":"21","author":"Lu","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1101\/gr.206805.116","article-title":"Engineered LINE-1 retrotransposition in nondividing human neurons","volume":"27","author":"Macia","year":"2017","journal-title":"Genome Res."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1523\/JNEUROSCI.4011-10.2011","article-title":"RTP801\/REDD1 regulates the timing of cortical neurogenesis and neuron migration","volume":"31","author":"Malagelada","year":"2011","journal-title":"J. Neurosci."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1111\/jcmm.17411","article-title":"Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome","volume":"26","author":"Martinez de Lagran","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature09544","article-title":"L1 retrotransposition in neurons is modulated by MeCP2","volume":"468","author":"Muotri","year":"2010","journal-title":"Nature"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"104692","DOI":"10.1016\/j.ebiom.2023.104692","article-title":"Dose imbalance of DYRK1A kinase causes systemic progeroid status in down syndrome by increasing the un-repaired DNA damage and reducing LaminB1 levels","volume":"94","author":"Murray","year":"2023","journal-title":"EBioMedicine"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/s41419-021-03899-y","article-title":"RTP801\/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer\u2019s disease","volume":"12","author":"P\u00e9rez-Sisqu\u00e9s","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.nbd.2013.08.008","article-title":"Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A","volume":"60","author":"Pons-Espinal","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-024-02440-9","article-title":"The lncRNA Snhg11, a new candidate contributing to neurogenesis, plasticity and memory deficits in down syndrome","author":"Sierra","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"e05196","DOI":"10.7554\/eLife.05196","article-title":"Dysregulated Dscam levels act through Abelson tyrosine kinase to enlarge presynaptic arbors","volume":"4","author":"Sterne","year":"2015","journal-title":"eLife"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.26.24303316","article-title":"A pilot study to investigate the safety and feasibility of antiretroviral therapy for Alzheimer\u2019s disease (ART-AD)","author":"Sullivan","year":"2024","journal-title":"medRxiv"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"R91","DOI":"10.1186\/gb-2007-8-5-r91","article-title":"Gene expression variation in Down\u2019s syndrome mice allows prioritization of candidate genes","volume":"8","author":"Sultan","year":"2007","journal-title":"Genome Biol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3389\/fgene.2019.01244","article-title":"Aberrantly high levels of somatic LINE-1 expression and Retrotransposition in human neurological disorders","volume":"10","author":"Terry","year":"2020","journal-title":"Front. Genet."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"Thorvaldsdottir","year":"2013","journal-title":"Brief. Bioinform."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1038\/s41598-021-85062-3","article-title":"Genetic dissection of down syndrome-associated alterations in APP\/amyloid-\u03b2 biology using mouse models","volume":"11","author":"Tosh","year":"2021","journal-title":"Sci. Rep."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3390\/ijms241311144","article-title":"Lamivudine (3TC), a nucleoside reverse transcriptase inhibitor, prevents the neuropathological alterations present in mutant tau transgenic mice","volume":"24","author":"Vall\u00e9s-Saiz","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1212\/NXG.0000000000000375","article-title":"Identification of TYW3\/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosis","volume":"5","author":"Wei","year":"2019","journal-title":"Neurol. Genet."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.stem.2019.04.014","article-title":"OLIG2 drives abnormal neurodevelopmental phenotypes in human iPSC-based organoid and chimeric mouse models of down syndrome","volume":"24","author":"Xu","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/hmg\/7.2.227","article-title":"DSCAM: a novel member of the immunoglobulin superfamily maps in a down syndrome region and is involved in the development of the nervous system","volume":"7","author":"Yamakawa","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"ClusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41417-018-0067-5","article-title":"LncRNA SNHG14 promotes inflammatory response induced by cerebral ischemia\/reperfusion injury through regulating miR-136-5p \/ROCK1","volume":"26","author":"Zhong","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1007\/s10571-021-01060-z","article-title":"TTC3-mediated protein quality control, a potential mechanism for cognitive impairment","volume":"42","author":"Zhou","year":"2022","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/jns.12222","article-title":"A novel mutation in the FGD4 gene causing Charcot-Marie-tooth disease","volume":"22","author":"Zis","year":"2017","journal-title":"J. Peripher. Nerv. Syst."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"5871","DOI":"10.2147\/CMAR.S200001","article-title":"ZNF488 is an independent prognostic indicator in nasopharyngeal carcinoma and promotes cell adhesion and proliferation via collagen IV\/FAK\/AKT\/cyclin D1 pathway","volume":"11","author":"Zong","year":"2019","journal-title":"Cancer Manag. Res."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1386944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T04:37:51Z","timestamp":1721363871000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1386944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":56,"alternative-id":["10.3389\/fnagi.2024.1386944"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1386944","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"article-number":"1386944"}}